Data search
Results for MligTC455_49072
| Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
|---|---|---|---|---|---|---|
| MligTC455_49072 | 2077 | 43.26 | Mlig455_045808 | Neo: - Age: Down-Up-Up Region-specific R2: 2.466 Region-enriched R2: 1.923/0.00002 |
Mlig455_045808 {REF} {Length: 1508} {RNA1509_9056} {RNA1310_56777} {RNA815_24608} |
Cumulative graph for MligTC455_49072
Region-enriched expression
| Region | logFC | logCPM | Pvalue | FDR | Specificity |
|---|---|---|---|---|---|
| RegionR1 | 1.215 | 5.638 | 0.05209 | 0.53607 | |
| RegionR2 | 1.923 | 5.638 | 0.00000 | 0.00002 | Specific for R2: 2.466 |
| RegionR3 | 0.675 | 5.638 | 0.02945 | 0.29428 | |
| RegionR4 | 0.724 | 5.638 | 0.05785 | 0.21258 | |
| RegionR5 | -0.203 | 5.638 | 0.52078 | 0.88353 | |
| RegionR6 | 0.024 | 5.638 | 0.93821 | 1.00000 | |
| RegionR7 | -1.466 | 5.638 | 0.00089 | 0.03218 | |
| RegionR8 | -2.891 | 5.638 | 0.00001 | 0.00075 |
Regeneration-enriched expression
| Region | logFC | logCPM | PValue | FDR | Specificity |
|---|---|---|---|---|---|
| RegenerationR1 | -1.116 | 5.638 | 0.16981 | 0.91300 | |
| RegenerationR2 | -1.231 | 5.638 | 0.00053 | 0.03139 | |
| RegenerationR3 | -0.914 | 5.638 | 0.01538 | 0.22665 | |
| RegenerationR4 | -0.898 | 5.638 | 0.02302 | 0.24348 | |
| RegenerationR5 | -0.395 | 5.638 | 0.30251 | 0.72986 | |
| RegenerationR6 | -1.224 | 5.638 | 0.00237 | 0.05510 | |
| RegenerationBL | -0.335 | 5.638 | 0.52990 | 0.88987 | |
| RegenerationTP | -0.706 | 5.638 | 0.29663 | 0.74182 |
Genes with expression patterns similar to MligTC455_49072
| Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | MligTC455_49072 | 2077 | 43.26 | Mlig455_045808 | Neo: - Age: Down-Up-Up Region-specific R2: 2.466 Region-enriched R2: 1.923/0.00002 |
6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_045808 {REF} {Length: 1508} {RNA1509_9056} {RNA1310_56777} {RNA815_24608} | |
| 2. | MligTC455_17802 | 4269 | 88.94 | Mlig455_014107, Mlig455_014119 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.293 Region-enriched R2: 4.660/0.00000 |
5.349 | 0.859 | 0.963 | 0.910 | 0.968 | 0.870 | 0.779 | Mlig455_014107 {REF} {Length: 768} {RNA1509_50290, RNA1509_8001} {RNA1310_50688, RNA1509_50290, RNA1509_8001} {RNA1509_50290, RNA1509_8001, RNA815_23571} Mlig455_014119 {REF} {Length: 789} {RNA1509_50290} {RNA1310_50688} {RNA815_23571} |
|
| 3. | MligTC455_17803 | 2158 | 44.95 | Mlig455_014128 | Neo: - Age: - Region-specific R2: 5.111 Region-enriched R2: 4.751/0.00000 |
5.33 | 0.859 | 0.963 | 0.910 | 0.967 | 0.873 | 0.758 | Mlig455_014128 {REF} {Length: 974} {RNA1509_50290} {RNA1310_50688} {RNA815_23571} | |
| 4. | MligTC455_47716 | 1445 | 30.1 | Mlig455_062374, Mlig455_062397 | Neo: - Age: Down-Up-Up Region-specific R2: 4.444 Region-enriched R2: 3.549/0.00000 |
4.665 | 0.934 | 0.960 | 0.884 | 0.930 | 0.957 | - | Mlig455_062374 {REF} {Length: 899} {RNA1509_16194} {RNA1310_50819.1} {RNA815_25538} Mlig455_062397 {REF} {Length: 907} {RNA1509_16194} {RNA1310_50819.1, RNA1509_16194} {RNA1509_16194, RNA815_25538} |
|
| 5. | MligTC455_44354 | 1240 | 25.82 | Mlig455_001577 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.349 Region-specific R2: 5.143 Region-enriched R2: 4.498/0.00000 Regeneration-downregulated R2: -2.807 Regeneration-depleted R2: -2.807 |
4.66 | 0.923 | 0.949 | 0.926 | 0.955 | 0.907 | - | Mlig455_001577 {REF} {Length: 1028} {RNA1509_23470, RNA1509_33941, RNA1509_57202} {RNA1310_49541.2, RNA1509_23470, RNA1509_33941, RNA1509_57202} {RNA1509_23470, RNA1509_33941, RNA1509_57202, RNA815_59782} | |
| 6. | MligTC455_40063 | 1170 | 24.37 | Mlig455_005633, Mlig455_005677, Mlig455_008693 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.272 Region-specific R2: 8.260 Region-enriched R2: 8.105/0.00000 |
MAGEL2, TRO | 4.539 | 0.825 | 0.950 | 0.904 | 0.939 | 0.921 | - | Mlig455_005633 {REF} {Length: 2008} {Pfam: PMG protein [PF05287.14, score=47.1]} {Human: ENSG00000067445, TRO, trophinin, [Score=65.1, Expect=1e-10]} {RNA1509_11063} {RNA1310_60276} {RNA815_42200} Mlig455_005677 {REF} {Length: 1823} {Human: ENSG00000254585, MAGEL2, MAGE family member L2, [RH, Score=67.8, Expect=1e-12]} {RNA1509_11063} {RNA1310_60276} {RNA815_42200} Mlig455_008693 {REF} {Length: 1327} {Pfam: PMG protein [PF05287.14, score=30.5]} {RNA1509_11063} {RNA1310_60276} {RNA815_42200} |
| 7. | MligTC455_48034 | 2940 | 61.24 | Mlig455_019197 | Neo: - Age: Down-Up-Down Region-specific R2: 3.626 Region-enriched R2: 3.016/0.00000 |
4.503 | 0.858 | 0.904 | 0.844 | 0.947 | 0.950 | - | Mlig455_019197 {REF} {Length: 837} {TRANSSPLICED} {RNA1509_18675, RNA1509_21674, RNA1509_29285, RNA1509_6143} {RNA1310_17472, RNA1509_18675, RNA1509_21674, RNA1509_29285, RNA1509_6143} {RNA1509_18675, RNA1509_21674, RNA1509_29285, RNA1509_6143, RNA815_19105} | |
| 8. | MligTC455_53239 | 733 | 15.27 | Mlig455_025537 | Neo: - Age: - Region-specific R2: 4.434 Region-enriched R2: 3.108/0.00000 |
4.468 | 0.908 | 0.962 | 0.840 | 0.932 | 0.826 | - | Mlig455_025537 {REF} {Length: 964} {Pfam: Low-density lipoprotein receptor domain class A [PF00057.20, score=28.0]} {Dmel: FBgn0051221, CG31221, [RH, Score=70.9, Expect=5e-15]} {Celegans: WBGene00010290, F58H1.7, [Score=63.9, Expect=8e-13]} {Smed: dd_Smed_v6_5576_0_1, dd_Smed_v6_5576_0_1, [RH, Score=168, Expect=2e-53]} {RNA1509_58542} {RNA1310_40950} {RNA815_19778.1} | |
| 9. | MligTC455_28559 | 6127 | 127.65 | Mlig455_028180 | Neo: - Age: - Region-specific R2: 2.829 Region-enriched R2: 1.854/0.00000 Regeneration-depleted BL: -1.839 |
SYT11 | 4.452 | 0.869 | 0.962 | 0.868 | 0.858 | 0.895 | - | Mlig455_028180 {REF} {Length: 2785} {Pfam: C2 domain [PF00168.32, score=161.4]} {Human: ENSG00000132718, SYT11, synaptotagmin 11, [RH, Score=305, Expect=7e-100]} {Mouse: ENSMUSG00000068923, Syt11, synaptotagmin XI, [RH, Score=306, Expect=2e-100]} {Dmel: FBgn0028400, Syt4, Synaptotagmin 4, [RH, Score=351, Expect=1e-117]} {Celegans: WBGene00004924, snt-4, SyNapTotagmin, [RH, Score=232, Expect=2e-72]} {Smed: dd_Smed_v6_7243_0_1, dd_Smed_v6_7243_0_1, [RH, Score=399, Expect=2e-137]} {RNA1509_303} {RNA1310_7615, RNA1509_303} {RNA1509_303, RNA815_4825} |
| 10. | MligTC455_28560 | 6060 | 126.24 | Mlig455_028251 | Neo: - Age: - Region-specific R2: 2.839 Region-enriched R2: 1.867/0.00000 Regeneration-depleted BL: -1.887 |
SYT11 | 4.449 | 0.871 | 0.962 | 0.872 | 0.860 | 0.884 | - | Mlig455_028251 {REF} {Length: 2851} {Pfam: C2 domain [PF00168.32, score=161.3]} {Human: ENSG00000132718, SYT11, synaptotagmin 11, [RH, Score=304, Expect=1e-99]} {Mouse: ENSMUSG00000068923, Syt11, synaptotagmin XI, [RH, Score=305, Expect=3e-100]} {Dmel: FBgn0028400, Syt4, Synaptotagmin 4, [RH, Score=353, Expect=3e-118]} {Celegans: WBGene00004924, snt-4, SyNapTotagmin, [RH, Score=233, Expect=4e-73]} {Smed: dd_Smed_v6_7243_0_1, dd_Smed_v6_7243_0_1, [RH, Score=397, Expect=6e-137]} {RNA1509_17703, RNA1509_303, RNA1509_58747} {RNA1310_7615, RNA1509_17703, RNA1509_58747} {RNA1509_17703, RNA1509_58747, RNA815_4825} |
| 11. | MligTC455_49825 | 543 | 11.31 | Mlig455_069114 | Neo: - Age: Down-Up-Up Region-specific R2: 4.806 Region-enriched R2: 3.936/0.00000 |
4.428 | 0.864 | 0.916 | 0.847 | 0.951 | 0.850 | - | Mlig455_069114 {REF} {Length: 828} {Celegans: WBGene00003748, nlp-10, Neuropeptide-Like Protein, [Score=40.0, Expect=9e-06]} {RNA1509_26665} {RNA1310_48731, RNA1509_26665} {RNA1509_26665, RNA815_24488} | |
| 12. | MligTC455_53240 | 1601 | 33.35 | Mlig455_025555 | Neo: - Age: - Region-specific R2: 4.178 Region-enriched R2: 2.883/0.00000 |
4.427 | 0.839 | 0.950 | 0.812 | 0.895 | 0.931 | - | Mlig455_025555 {REF} {Length: 2163} {Pfam: Low-density lipoprotein receptor domain class A [PF00057.20, score=28.0]} {Dmel: FBgn0051221, CG31221, [RH, Score=69.7, Expect=2e-14]} {Celegans: WBGene00010290, F58H1.7, [Score=64.7, Expect=4e-13]} {Smed: dd_Smed_v6_2598_0_1, dd_Smed_v6_2598_0_1, [RH, Score=168, Expect=3e-53]} {RNA1509_58542} {RNA1310_40950, RNA1509_58542} {RNA1509_58542, RNA815_19778.1} | |
| 13. | MligTC455_19069 | 3067 | 63.89 | Mlig455_006883 | Neo: - Age: - Region-specific R2: 2.330 Region-enriched R2: 1.710/0.00004 Regeneration-downregulated BL: -1.680 Regeneration-depleted BL: -1.680 |
4.404 | 0.795 | 0.897 | 0.876 | 0.881 | 0.955 | - | Mlig455_006883 {REF} {Length: 1337} {RNA1509_18484} {RNA1310_63073.1} {RNA815_40214.1} | |
| 14. | MligTC455_25072 | 4443 | 92.56 | Mlig455_015899 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-1.175 Region-enriched R2: 4.389/0.00000 |
PI16 | 4.353 | 0.776 | 0.864 | 0.824 | 0.956 | 0.933 | - | Mlig455_015899 {REF} {Length: 2017} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=71.8]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=112, Expect=1e-26]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [RH, Score=115, Expect=5e-28]} {Dmel: FBgn0038126, CG8483, [Score=95.5, Expect=2e-21]} {Celegans: WBGene00011462, vap-2, Venom-Allergen-like Protein, [RH, Score=85.5, Expect=5e-18]} {Smed: dd_Smed_v6_2512_0_1, dd_Smed_v6_2512_0_1, [Score=140, Expect=2e-39]} {RNA1509_5027} {RNA1310_1356.1} {RNA815_4508} |
| 15. | MligTC455_40332 | 2776 | 57.83 | Mlig455_025589 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=-0.991 Region-specific R2: 3.549 Region-enriched R2: 2.897/0.00000 Regeneration-downregulated R2: -2.326 Regeneration-depleted R2: -2.326 |
4.35 | 0.768 | 0.850 | 0.960 | 0.860 | 0.912 | - | Mlig455_025589 {REF} {Length: 728} {RNA1509_15938, RNA1509_8175} {RNA1310_60401, RNA1509_15938, RNA1509_8175} {RNA1509_15938, RNA1509_8175, RNA815_36308} | |
| 16. | MligTC455_25382 | 4668 | 97.26 | Mlig455_000103, Mlig455_063773 | Neo: - Age: - Region-specific R2: 3.508 Region-enriched R2: 3.123/0.00000 |
4.302 | 0.873 | 0.952 | 0.904 | 0.745 | 0.828 | - | Mlig455_000103 {REF} {Length: 990} {RNA1509_36813} {RNA1310_39295, RNA1509_36813} {RNA1509_36813, RNA815_13177} Mlig455_063773 {REF} {Length: 890} {RNA1509_6028} {RNA1310_39295} {RNA815_13177} |
|
| 17. | MligTC455_46009 | 5464 | 113.82 | Mlig455_061251, Mlig455_062639 | Neo: - Age: logFC(26M/2M)=-0.276 Region-specific R2: 2.871 Region-enriched R2: 2.103/0.00001 |
4.279 | - | 0.954 | 0.793 | 0.877 | 0.917 | 0.738 | Mlig455_061251 {REF} {Length: 1343} {Smed: dd_Smed_v6_1520_0_1, dd_Smed_v6_1520_0_1, [Score=54.7, Expect=6e-10]} {RNA1509_3086} {RNA1310_72677.2} {RNA815_25863} Mlig455_062639 {REF} {Length: 1176} {Smed: dd_Smed_v6_1520_0_1, dd_Smed_v6_1520_0_1, [Score=54.7, Expect=6e-10]} {RNA1509_3086} {RNA1310_72677.2} {RNA815_25863} |
|
| 18. | MligTC455_41968 | 247 | 5.15 | Mlig455_048152 | Neo: - Age: - Region-specific R2: 5.996 Region-enriched R2: 5.206/0.00199 |
3.755 | - | 0.956 | 0.904 | 0.941 | 0.954 | - | Mlig455_048152 {REF} {Length: 932} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=22.6]} {RNA1509_40628} {RNA1310_50753} {RNA815_21607} | |
| 19. | MligTC455_17628 | 869 | 18.11 | Mlig455_036459 | Neo: - Age: Down-Up-Up |
3.75 | - | 0.952 | 0.869 | 0.965 | 0.964 | - | Mlig455_036459 {REF} {Length: 1261} {RNA1509_16798} {RNA1310_48718, RNA1509_16798} {RNA1509_16798, RNA815_24350} | |
| 20. | MligTC455_42313 | 496 | 10.33 | Mlig455_047802 | Neo: - Age: Down-Up-Up Region-specific R2: 5.966 Region-enriched R2: 4.823/0.00000 Regeneration-downregulated R2: -2.674 Regeneration-depleted R2: -2.674 |
3.696 | - | 0.944 | 0.862 | 0.956 | 0.934 | - | Mlig455_047802 {REF} {Length: 1225} {Pfam: Hyaluronidase protein (HylP) [PF07212.13, score=21.5]} {RNA1509_51722} {RNA1310_51935, RNA1509_51722} {RNA1509_51722, RNA815_15783.2} | |
| 21. | MligTC455_46924 | 1562 | 32.53 | Mlig455_042561 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.240 Region-enriched R2: 5.226/0.00021 |
PI16 | 3.687 | - | 0.930 | 0.934 | 0.866 | 0.957 | - | Mlig455_042561 {REF} {Length: 1929} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=59.8]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=75.5, Expect=4e-14]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [Score=78.6, Expect=3e-15]; ENSMUSG00000020213, Glipr1l1, GLI pathogenesis-related 1 like 1, [Score=75.1, Expect=5e-15]} {Dmel: FBgn0038126, CG8483, [Score=65.9, Expect=2e-11]} {Celegans: WBGene00003055, lon-1, LONg, [Score=65.9, Expect=7e-12]} {Smed: dd_Smed_v6_2021_0_1, dd_Smed_v6_2021_0_1, [RH, Score=140, Expect=2e-36]} {RNA1509_33691, RNA1509_4403} {RNA1310_19427.1, RNA1509_33691, RNA1509_4403} {RNA1509_33691, RNA1509_4403, RNA815_7689.1} |
| 22. | MligTC455_44328 | 858 | 17.88 | Mlig455_026172 | Neo: - Age: Down-Up-Up Region-specific R2: 4.714 Region-enriched R2: 4.385/0.00000 |
3.683 | - | 0.947 | 0.904 | 0.963 | 0.869 | - | Mlig455_026172 {REF} {Length: 661} {RNA1509_32102, RNA1509_34635} {RNA1310_60068, RNA1509_32102, RNA1509_34635} {RNA1509_32102, RNA1509_34635, RNA815_37486} | |
| 23. | MligTC455_44713 | 661 | 13.77 | Mlig455_048154 | Neo: - Age: logFC(26M/2M)=0.569 Region-specific R2: 3.883 Region-enriched R2: 3.422/0.00000 |
3.66 | - | 0.933 | 0.913 | 0.958 | 0.856 | - | Mlig455_048154 {REF} {Length: 1173} {RNA1509_34252} {RNA1310_54269.1} {RNA815_55074} | |
| 24. | MligTC455_14684 | 7049 | 146.85 | Mlig455_051414 | Neo: - Age: - Region-specific R2: 2.287 Region-enriched R2: 1.764/0.00001 Regeneration-depleted BL: -2.197 |
PAM | 3.645 | 0.836 | 0.958 | 0.903 | - | 0.948 | - | Mlig455_051414 {REF} {Length: 1674} {TRANSSPLICED} {Pfam: NHL repeat [PF01436.23, score=89.1]} {Human: ENSG00000145730, PAM, peptidylglycine alpha-amidating monooxygenase, [RH, Score=194, Expect=4e-55]} {Mouse: ENSMUSG00000026335, Pam, peptidylglycine alpha-amidating monooxygenase, [Score=201, Expect=4e-57]} {Dmel: FBgn0262728, Pal2, Peptidyl-alpha-hydroxyglycine-alpha-amidating lyase 2, [RH, Score=206, Expect=4e-62]} {Celegans: WBGene00017671, pgal-1, Probable peptidyl-alpha-hydroxyglycine alpha-amidating lyase pgal-1, [RH, Score=206, Expect=3e-63]} {Smed: dd_Smed_v6_3093_0_1, dd_Smed_v6_3093_0_1, [RH, Score=249, Expect=2e-79]} {RNA1509_910} {RNA1310_18216.1, RNA1509_910} {RNA1509_910, RNA815_736.1} |
| 25. | MligTC455_45414 | 4030 | 83.95 | Mlig455_045096 | Neo: - Age: Down-Down-Up Region-specific R2: 2.245 Region-enriched R2: 1.386/0.00025 Regeneration-depleted TP: -1.938 |
3.633 | - | 0.960 | 0.874 | 0.923 | 0.876 | - | Mlig455_045096 {REF} {Length: 1427} {RNA1509_17049, RNA1509_18052, RNA1509_29416, RNA1509_54192} {RNA1310_24092, RNA1509_17049, RNA1509_18052, RNA1509_29416, RNA1509_54192} {RNA1509_17049, RNA1509_18052, RNA1509_29416, RNA1509_54192, RNA815_369.1} | |
| 26. | MligTC455_49863 | 62 | 1.29 | Mlig455_019320, Mlig455_019542 | Neo: - Age: - |
SHOX2 | 3.62 | - | 0.953 | 0.874 | 0.915 | 0.878 | - | Mlig455_019320 {REF} {Length: 1251} {Pfam: Homeodomain [PF00046.31, score=83.4]; Homeobox KN domain [PF05920.13, score=23.0]} {Human: ENSG00000168779, SHOX2, short stature homeobox 2, [Score=88.2, Expect=5e-21]; ENSG00000185960, SHOX, short stature homeobox, [Score=86.3, Expect=7e-20]} {Mouse: ENSMUSG00000027833, Shox2, short stature homeobox 2, [Score=88.2, Expect=3e-21]} {Dmel: FBgn0085396, CG34367, [Score=89.4, Expect=7e-21]} {Celegans: WBGene00006744, unc-4, Homeobox protein unc-4, [Score=84.0, Expect=2e-19]} {Smed: dd_Smed_v6_22163_0_1, dd_Smed_v6_22163_0_1, [Score=87.0, Expect=8e-20]} {RNA1310_51707} {RNA815_41055} Mlig455_019542 {REF} {Length: 1249} {Pfam: Homeodomain [PF00046.31, score=83.4]; Homeobox KN domain [PF05920.13, score=23.0]} {Human: ENSG00000168779, SHOX2, short stature homeobox 2, [Score=88.6, Expect=4e-21]; ENSG00000185960, SHOX, short stature homeobox, [Score=86.3, Expect=6e-20]} {Mouse: ENSMUSG00000027833, Shox2, short stature homeobox 2, [Score=88.6, Expect=3e-21]} {Dmel: FBgn0085396, CG34367, [Score=89.4, Expect=7e-21]} {Celegans: WBGene00006744, unc-4, Homeobox protein unc-4, [Score=86.7, Expect=3e-20]} {Smed: dd_Smed_v6_22163_0_1, dd_Smed_v6_22163_0_1, [Score=87.0, Expect=8e-20]} {RNA1310_51707} {RNA815_41055} |
| 27. | MligTC455_49073 | 824 | 17.17 | Mlig455_063174 | Neo: - Age: Down-Down-Up Region-specific R2: 4.151 Region-enriched R2: 3.105/0.00023 |
3.599 | - | 0.927 | 0.762 | 0.983 | 0.927 | - | Mlig455_063174 {REF} {Length: 1083} {RNA1509_9056} {RNA1310_56777} {RNA815_24608} | |
| 28. | MligTC455_50172 | 243 | 5.05 | Mlig455_067182 | Neo: - Age: Down-Up-Up Region-specific R2: 6.036 Region-enriched R2: 6.524/0.00000 |
3.597 | - | 0.945 | 0.855 | 0.955 | 0.842 | - | Mlig455_067182 {REF} {Length: 638} {Pfam: Pancreatic hormone peptide [PF00159.20, score=47.5]} {RNA1509_60030} {RNA1310_56761, RNA1509_60030} {RNA1509_60030, RNA815_31877.1} | |
| 29. | MligTC455_20574 | 3347 | 69.74 | Mlig455_021418 | Neo: - Age: - |
PCSK2 | 3.586 | - | 0.966 | 0.797 | 0.878 | 0.945 | - | Mlig455_021418 {REF} {Length: 1212} {Pfam: Peptidase S8 pro-domain [PF16470.7, score=47.7]} {Human: ENSG00000125851, PCSK2, proprotein convertase subtilisin/kexin type 2, [Score=53.9, Expect=2e-08]} {Mouse: ENSMUSG00000027419, Pcsk2, proprotein convertase subtilisin/kexin type 2, [Score=52.8, Expect=4e-08]} {Dmel: FBgn0023179, amon, amontillado, [Score=55.8, Expect=2e-09]} {Celegans: WBGene00001172, egl-3, Neuroendocrine convertase 2, [Score=61.2, Expect=3e-11]} {Smed: dd_Smed_v6_1566_0_1, dd_Smed_v6_1566_0_1, [Score=65.1, Expect=1e-12]} {RNA1509_15978} {RNA1310_7333.1} {RNA815_2403.2} |
| 30. | MligTC455_53546 | 130 | 2.72 | Mlig455_013326, Mlig455_013334 | Neo: - Age: - Region-enriched R2: 6.753/0.01892 |
MMP9 | 3.558 | - | 0.893 | 0.801 | 0.960 | 0.904 | - | Mlig455_013326 {REF} {Length: 1449} {Pfam: Fibronectin type II domain [PF00040.21, score=92.5]} {Human: ENSG00000100985, MMP9, matrix metallopeptidase 9, [RH, Score=87.8, Expect=3e-18]} {Mouse: ENSMUSG00000017737, Mmp9, matrix metallopeptidase 9, [RH, Score=82.4, Expect=1e-16]; ENSMUSG00000031740, Mmp2, matrix metallopeptidase 2, [RH, Score=78.6, Expect=2e-15]} {Smed: dd_Smed_v6_14558_0_1, dd_Smed_v6_14558_0_1, [RH, Score=138, Expect=3e-38]} {RNA1310_38631} {RNA815_51136} Mlig455_013334 {REF} {Length: 1398} {Pfam: Fibronectin type II domain [PF00040.21, score=92.1]} {Human: ENSG00000100985, MMP9, matrix metallopeptidase 9, [RH, Score=89.4, Expect=1e-18]} {Mouse: ENSMUSG00000017737, Mmp9, matrix metallopeptidase 9, [RH, Score=84.0, Expect=4e-17]} {Smed: dd_Smed_v6_12601_0_1, dd_Smed_v6_12601_0_1, [RH, Score=140, Expect=2e-38]} {RNA1310_38631} {RNA815_51136} |
| 31. | MligTC455_53580 | 10830 | 225.63 | Mlig455_061858 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.371 Region-specific R2: 2.295 Region-enriched R2: 1.602/0.00040 Regeneration-downregulated BL: -1.692 Regeneration-depleted BL: -1.692 |
3.553 | 0.844 | 0.965 | - | 0.827 | 0.917 | - | Mlig455_061858 {REF} {Length: 1839} {Pfam: Neuroendocrine protein 7B2 precursor (Secretogranin V) [PF05281.13, score=32.7]} {Smed: dd_Smed_v6_3862_0_1, dd_Smed_v6_3862_0_1, [Score=77.4, Expect=9e-17]} {RNA1509_2808} {RNA1310_24594} {RNA815_8289} | |
| 32. | MligTC455_53581 | 10826 | 225.54 | Mlig455_061865 | Neo: - Age: Down-Down-Up Region-specific R2: 2.296 Region-enriched R2: 1.603/0.00040 Regeneration-downregulated BL: -1.690 Regeneration-depleted BL: -1.690 |
3.553 | 0.844 | 0.965 | - | 0.827 | 0.917 | - | Mlig455_061865 {REF} {Length: 1605} {Pfam: Neuroendocrine protein 7B2 precursor (Secretogranin V) [PF05281.13, score=82.0]} {Dmel: FBgn0041707, 7B2, [RH, Score=70.1, Expect=1e-13]} {Celegans: WBGene00011392, sbt-1, Seven B Two (Mammalian 7BT prohormone convertase chaperone) homolog, [RH, Score=67.4, Expect=4e-13]} {Smed: dd_Smed_v6_3862_0_1, dd_Smed_v6_3862_0_1, [RH, Score=118, Expect=1e-31]} {RNA1509_1202, RNA1509_24767} {RNA1310_24594, RNA1509_24767} {RNA1509_24767, RNA815_8289} | |
| 33. | MligTC455_44025 | 591 | 12.31 | Mlig455_050980 | Neo: - Age: - Region-specific R2: 5.366 Region-enriched R2: 5.986/0.00000 |
3.535 | - | 0.950 | 0.811 | 0.850 | 0.924 | - | Mlig455_050980 {REF} {Length: 587} {Smed: dd_Smed_v6_2575_0_1, dd_Smed_v6_2575_0_1, [Score=49.7, Expect=7e-09]} {RNA1509_52032} {RNA1310_52449.2} {RNA815_56904} | |
| 34. | MligTC455_14683 | 2425 | 50.53 | Mlig455_039611 | Neo: - Age: Down-Up-Up |
PAM | 3.535 | 0.821 | 0.972 | 0.815 | - | 0.927 | - | Mlig455_039611 {REF} {Length: 1708} {Pfam: NHL repeat [PF01436.23, score=88.3]} {Human: ENSG00000145730, PAM, peptidylglycine alpha-amidating monooxygenase, [RH, Score=191, Expect=5e-54]} {Mouse: ENSMUSG00000026335, Pam, peptidylglycine alpha-amidating monooxygenase, [Score=198, Expect=4e-56]} {Dmel: FBgn0262728, Pal2, Peptidyl-alpha-hydroxyglycine-alpha-amidating lyase 2, [RH, Score=206, Expect=2e-62]} {Celegans: WBGene00017671, pgal-1, Probable peptidyl-alpha-hydroxyglycine alpha-amidating lyase pgal-1, [RH, Score=204, Expect=2e-62]} {Smed: dd_Smed_v6_3093_0_1, dd_Smed_v6_3093_0_1, [RH, Score=251, Expect=4e-80]} {RNA1509_910, RNA1509_9422} {RNA1310_18216.1, RNA1509_9422} {RNA1509_9422, RNA815_736.1} |
| 35. | MligTC455_08837 | 2734 | 56.96 | Mlig455_047253, Mlig455_047306 | Neo: - Age: - Region-specific R2: 4.689 Region-enriched R2: 4.490/0.00000 |
3.52 | 0.802 | 0.913 | 0.832 | - | 0.973 | - | Mlig455_047253 {REF} {Length: 3106} {TRANSSPLICED} {Pfam: Pancreatic hormone peptide [PF00159.20, score=46.0]} {Smed: dd_Smed_v6_16946_0_1, dd_Smed_v6_16946_0_1, [Score=41.6, Expect=3e-06]} {RNA1509_19067, RNA1509_27231} {RNA1310_388.2, RNA1509_19067} {RNA1509_19067, RNA815_3901} Mlig455_047306 {REF} {Length: 3098} {Pfam: Pancreatic hormone peptide [PF00159.20, score=46.0]} {Smed: dd_Smed_v6_16946_0_1, dd_Smed_v6_16946_0_1, [Score=42.0, Expect=2e-06]} {RNA1509_27231} {RNA1310_388.2, RNA1509_27231} {RNA1509_27231, RNA815_3901} |
|
| 36. | MligTC455_50362 | 295 | 6.16 | Mlig455_012011 | Neo: - Age: logFC(26M/2M)=1.080 Region-enriched R2: 3.396/0.00236 |
3.519 | - | 0.883 | 0.952 | 0.957 | 0.727 | - | Mlig455_012011 {REF} {Length: 947} {RNA1509_58656} {RNA1310_57201.1} {RNA815_30531.1} | |
| 37. | MligTC455_16166 | 638 | 13.28 | Mlig455_045546, Mlig455_052637 | Neo: - Age: - |
B3GALT5 | 3.509 | - | 0.870 | 0.899 | 0.959 | 0.781 | - | Mlig455_045546 {REF} {Length: 2520} {Pfam: Galactosyltransferase [PF01762.23, score=159.0]} {Human: ENSG00000183778, B3GALT5, beta-1,3-galactosyltransferase 5, [RH, Score=129, Expect=2e-32]} {Mouse: ENSMUSG00000034780, B3galt1, UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1, [Score=113, Expect=5e-27]; ENSMUSG00000074892, B3galt5, UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5, [Score=111, Expect=2e-26]; ENSMUSG00000074004, B3gnt6, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase), [Score=110, Expect=1e-25]} {Dmel: FBgn0035558, CG11357, [RH, Score=147, Expect=3e-38]} {Celegans: WBGene00000270, bre-5, Beta-1,3-galactosyltransferase bre-5, [Score=72.8, Expect=3e-14]} {Smed: dd_Smed_v6_12783_0_1, dd_Smed_v6_12783_0_1, [Score=149, Expect=5e-40]} {RNA1509_45540} {RNA1310_2435} {RNA815_25407} Mlig455_052637 {REF} {Length: 2225} {Pfam: Galactosyltransferase [PF01762.23, score=159.1]} {Human: ENSG00000183778, B3GALT5, beta-1,3-galactosyltransferase 5, [RH, Score=125, Expect=3e-31]} {Mouse: ENSMUSG00000034780, B3galt1, UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1, [Score=114, Expect=1e-27]; ENSMUSG00000074004, B3gnt6, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase), [Score=109, Expect=3e-25]} {Dmel: FBgn0035558, CG11357, [Score=143, Expect=1e-36]} {Celegans: WBGene00000270, bre-5, Beta-1,3-galactosyltransferase bre-5, [Score=71.2, Expect=3e-13]} {Smed: dd_Smed_v6_12783_0_1, dd_Smed_v6_12783_0_1, [Score=152, Expect=3e-41]} {RNA1509_45540} {RNA1310_2435} {RNA815_25407} |
| 38. | MligTC455_47792 | 666 | 13.88 | Mlig455_041913 | Neo: - Age: - Region-specific R2: 4.721 Region-enriched R2: 5.442/0.00000 |
3.507 | - | 0.868 | 0.859 | 0.963 | 0.817 | - | Mlig455_041913 {REF} {Length: 603} {RNA1509_14790} {RNA1310_58119} {RNA815_32986} | |
| 39. | MligTC455_14685 | 3975 | 82.82 | Mlig455_051429 | Neo: - Age: - Region-specific R2: 2.895 Region-enriched R2: 2.262/0.00004 |
PAM | 3.475 | 0.707 | 0.948 | 0.854 | - | 0.966 | - | Mlig455_051429 {REF} {Length: 1911} {Pfam: NHL repeat [PF01436.23, score=59.1]} {Human: ENSG00000145730, PAM, peptidylglycine alpha-amidating monooxygenase, [Score=119, Expect=2e-28]} {Mouse: ENSMUSG00000026335, Pam, peptidylglycine alpha-amidating monooxygenase, [Score=115, Expect=2e-27]} {Dmel: FBgn0262728, Pal2, Peptidyl-alpha-hydroxyglycine-alpha-amidating lyase 2, [Score=115, Expect=2e-28]} {Celegans: WBGene00017671, pgal-1, Probable peptidyl-alpha-hydroxyglycine alpha-amidating lyase pgal-1, [Score=125, Expect=2e-32]} {Smed: dd_Smed_v6_3093_0_1, dd_Smed_v6_3093_0_1, [Score=138, Expect=4e-37]} {RNA1509_910} {RNA1310_18216.1} {RNA815_736.1} |
| 40. | MligTC455_44862 | 1318 | 27.47 | Mlig455_028792 | Neo: - Age: - Region-enriched R2: 3.389/0.00000 |
QPCT | 3.472 | - | 0.851 | 0.815 | 0.968 | 0.838 | - | Mlig455_028792 {REF} {Length: 1901} {Pfam: Peptidase family M28 [PF04389.19, score=137.7]} {Human: ENSG00000115828, QPCT, glutaminyl-peptide cyclotransferase, [RH, Score=189, Expect=5e-57]; ENSG00000011478, QPCTL, glutaminyl-peptide cyclotransferase like, [RH, Score=186, Expect=1e-55]} {Mouse: ENSMUSG00000030407, Qpctl, glutaminyl-peptide cyclotransferase-like, [RH, Score=190, Expect=3e-57]; ENSMUSG00000024084, Qpct, glutaminyl-peptide cyclotransferase (glutaminyl cyclase), [RH, Score=189, Expect=5e-57]} {Dmel: FBgn0036999, isoQC, iso Glutaminyl cyclase, [RH, Score=210, Expect=2e-65]} {Celegans: WBGene00010418, H27A22.1, [Score=182, Expect=5e-55]} {Smed: dd_Smed_v6_4861_0_2, dd_Smed_v6_4861_0_2, [Score=166, Expect=1e-48]} {RNA1509_15042, RNA1509_18145} {RNA1310_21749, RNA1509_15042, RNA1509_18145} {RNA1509_15042, RNA1509_18145, RNA815_8635.1} |
| 41. | MligTC455_36373 | 2360 | 49.17 | Mlig455_008690 | Neo: - Age: - Region-enriched R2: 7.147/0.00000 |
3.462 | 0.784 | 0.779 | 0.936 | 0.963 | - | - | Mlig455_008690 {REF} {Length: 1552} {RNA1509_2189} {RNA1310_71597} {RNA815_31926.1} | |
| 42. | MligTC455_53579 | 15576 | 324.49 | Mlig455_010515 | Neo: - Age: - Region-enriched R2: 1.446/0.00265 Regeneration-downregulated BL: -1.566 Regeneration-depleted BL: -1.566 |
3.461 | 0.820 | 0.957 | - | 0.867 | 0.817 | - | Mlig455_010515 {REF} {Length: 1448} {Pfam: Neuroendocrine protein 7B2 precursor (Secretogranin V) [PF05281.13, score=80.3]} {Dmel: FBgn0041707, 7B2, [RH, Score=70.1, Expect=2e-13]} {Celegans: WBGene00011392, sbt-1, Seven B Two (Mammalian 7BT prohormone convertase chaperone) homolog, [RH, Score=67.4, Expect=5e-13]} {Smed: dd_Smed_v6_3862_0_1, dd_Smed_v6_3862_0_1, [RH, Score=119, Expect=7e-32]} {RNA1509_1202, RNA1509_1348, RNA1509_17830} {RNA1310_24594, RNA1509_1202, RNA1509_1348, RNA1509_17830} {RNA1509_1202, RNA1509_1348, RNA1509_17830, RNA815_8289} | |
| 43. | MligTC455_53860 | 202 | 4.22 | Mlig455_053523, Mlig455_061000 | Neo: - Age: Up-Down-Down Region-enriched R2: 3.086/0.02665 |
RGS3 | 3.441 | - | 0.767 | 0.786 | 0.933 | 0.955 | - | Mlig455_053523 {REF} {Length: 2125} {Pfam: Regulator of G protein signaling domain [PF00615.21, score=117.0]} {Human: ENSG00000138835, RGS3, regulator of G protein signaling 3, [RH, Score=163, Expect=4e-45]} {Mouse: ENSMUSG00000059810, Rgs3, regulator of G-protein signaling 3, [RH, Score=165, Expect=2e-45]} {Dmel: FBgn0028743, Dhit, Double hit, [Score=109, Expect=2e-27]} {Celegans: WBGene00004350, rgs-7, Regulator of G-protein signaling rgs-7, [RH, Score=130, Expect=1e-34]} {Smed: dd_Smed_v6_8787_0_1, dd_Smed_v6_8787_0_1, [Score=173, Expect=9e-51]} {RNA1310_19330.1} {RNA815_18723} Mlig455_061000 {REF} {Length: 2721} {Pfam: Regulator of G protein signaling domain [PF00615.21, score=117.0]; Dehydrin [PF00257.21, score=20.5]} {Human: ENSG00000138835, RGS3, regulator of G protein signaling 3, [RH, Score=163, Expect=4e-45]} {Mouse: ENSMUSG00000059810, Rgs3, regulator of G-protein signaling 3, [RH, Score=165, Expect=2e-45]} {Dmel: FBgn0028743, Dhit, Double hit, [Score=109, Expect=2e-27]} {Celegans: WBGene00004350, rgs-7, Regulator of G-protein signaling rgs-7, [RH, Score=130, Expect=1e-34]} {Smed: dd_Smed_v6_8787_0_1, dd_Smed_v6_8787_0_1, [Score=173, Expect=8e-51]} {RNA1310_19330.1} {RNA815_18723} |
| 44. | MligTC455_17586 | 579 | 12.07 | Mlig455_029070 | Neo: - Age: - Region-specific R2: 3.959 Region-enriched R2: 2.423/0.00859 Regeneration-downregulated R6: -3.050 Regeneration-depleted R6: -3.050 |
3.409 | - | 0.733 | 0.775 | 0.942 | 0.959 | - | Mlig455_029070 {REF} {Length: 859} {RNA1509_53221, RNA1509_56226} {RNA1310_52775.1, RNA1509_53221, RNA1509_56226} {RNA1509_53221, RNA1509_56226, RNA815_35656} | |
| 45. | MligTC455_16846 | 158 | 3.3 | Mlig455_051873 | Neo: - Age: Down-Up-Up Region-enriched R2: 5.265/0.00110 |
PRSS33 | 3.405 | - | 0.720 | 0.791 | 0.935 | 0.959 | - | Mlig455_051873 {REF} {Length: 1386} {Pfam: Trypsin [PF00089.28, score=189.9]; Domain of unknown function (DUF1986) [PF09342.13, score=27.5]; Trypsin-like peptidase domain [PF13365.8, score=26.9]} {Human: ENSG00000103355, PRSS33, serine protease 33, [Score=159, Expect=4e-46]} {Mouse: ENSMUSG00000016942, Tmprss6, transmembrane serine protease 6, [Score=154, Expect=4e-41]; ENSMUSG00000037129, Tmprss13, transmembrane protease, serine 13, [Score=150, Expect=2e-40]; ENSMUSG00000059406, Tmprss9, transmembrane protease, serine 9, [Score=148, Expect=6e-39]} {Dmel: FBgn0036287, CG10663, [Score=146, Expect=1e-38]} {Celegans: WBGene00006620, svh-1, HGF/MSP/plasminogen-like protein, [Score=125, Expect=2e-31]} {Smed: dd_Smed_v6_10267_0_1, dd_Smed_v6_10267_0_1, [Score=178, Expect=3e-53]} {RNA1509_26566} {RNA1310_23561} {RNA815_9840} |
| 46. | MligTC455_44329 | 510 | 10.62 | Mlig455_026184, Mlig455_026199 | Neo: - Age: - Region-specific R2: 5.127 Region-enriched R2: 4.824/0.00000 |
3.397 | - | 0.778 | 0.844 | 0.955 | 0.820 | - | Mlig455_026184 {REF} {Length: 724} {RNA1509_29216, RNA1509_32102} {RNA1310_60068, RNA1509_29216} {RNA1509_29216, RNA815_37486} Mlig455_026199 {REF} {Length: 531} {RNA1509_32102} {RNA1310_60068} {RNA815_37486} |
|
| 47. | MligTC455_17562 | 108 | 2.25 | Mlig455_022496 | Neo: - Age: - |
NECAB3 | 3.353 | - | 0.802 | 0.705 | 0.964 | 0.882 | - | Mlig455_022496 {REF} {Length: 1499} {Pfam: EF hand [PF00036.34, score=34.0]; EF-hand domain [PF13405.8, score=33.4]; EF-hand domain pair [PF13833.8, score=29.2]; EF-hand domain pair [PF13499.8, score=28.3]; Antibiotic biosynthesis monooxygenase [PF03992.18, score=22.0]; EF hand [PF13202.8, score=21.3]} {Human: ENSG00000125967, NECAB3, N-terminal EF-hand calcium binding protein 3, [RH, Score=189, Expect=7e-57]; ENSG00000123119, NECAB1, N-terminal EF-hand calcium binding protein 1, [RH, Score=186, Expect=1e-55]} {Mouse: ENSMUSG00000040536, Necab1, N-terminal EF-hand calcium binding protein 1, [RH, Score=191, Expect=7e-58]; ENSMUSG00000027489, Necab3, N-terminal EF-hand calcium binding protein 3, [RH, Score=191, Expect=9e-58]} {RNA1509_46831} {RNA1310_24461} {RNA815_25216} |
| 48. | MligTC455_36153 | 63 | 1.31 | Mlig455_068201 | Neo: - Age: Up-Down-Down |
ZFYVE9 | 3.352 | - | 0.745 | 0.791 | 0.962 | 0.854 | - | Mlig455_068201 {REF} {Length: 2852} {Pfam: Domain of unknown function (DUF3480) [PF11979.10, score=106.6]} {Human: ENSG00000157077, ZFYVE9, zinc finger FYVE-type containing 9, [Score=132, Expect=5e-32]} {Mouse: ENSMUSG00000034557, Zfyve9, zinc finger, FYVE domain containing 9, [Score=134, Expect=7e-33]} {Dmel: FBgn0026369, Sara, Smad anchor for receptor activation, [Score=122, Expect=6e-29]} {Celegans: WBGene00000101, aka-1, A Kinase Anchor protein; A kinase anchor protein, [Score=50.1, Expect=3e-06]} {Smed: dd_Smed_v6_8098_0_1, dd_Smed_v6_8098_0_1, [Score=82.4, Expect=2e-16]} {RNA1509_39700} {RNA1310_6234.1} {RNA815_2939.1} |
| 49. | MligTC455_38699 | 267 | 5.56 | Mlig455_054929 | Neo: - Age: Up-Down-Down Region-enriched R2: 2.183/0.01222 |
COLEC10 | 3.327 | - | 0.783 | 0.845 | 0.976 | 0.723 | - | Mlig455_054929 {REF} {Length: 1403} {Pfam: Lectin C-type domain [PF00059.23, score=45.4]} {Human: ENSG00000184374, COLEC10, collectin subfamily member 10, [Score=50.4, Expect=2e-07]} {Mouse: ENSMUSG00000038591, Colec10, collectin sub-family member 10, [Score=47.8, Expect=1e-06]} {RNA1509_22697} {RNA1310_23822} {RNA815_11460} |
| 50. | MligTC455_41824 | 194 | 4.03 | Mlig455_048229 | Neo: - Age: - Region-enriched R2: 3.040/0.03860 |
3.319 | 0.780 | 0.719 | 0.856 | 0.964 | - | - | Mlig455_048229 {REF} {Length: 769} {RNA1509_49797} {RNA1310_60350, RNA1509_49797} {RNA1509_49797, RNA815_30999} | |
| 51. | MligTC455_15726 | 270 | 5.63 | Mlig455_031204 | Neo: - Age: - Region-enriched R2: 6.820/0.00015 |
ADAMTS18 | 3.3 | - | 0.796 | 0.776 | 0.774 | 0.954 | - | Mlig455_031204 {REF} {Length: 2405} {Pfam: Reprolysin (M12B) family zinc metalloprotease [PF01421.21, score=77.6]; Metallo-peptidase family M12 [PF13688.8, score=52.5]; Metallo-peptidase family M12B Reprolysin-like [PF13583.8, score=45.6]; Metallo-peptidase family M12B Reprolysin-like [PF13582.8, score=41.4]; ADAM cysteine-rich domain [PF17771.3, score=40.0]; Metallo-peptidase family M12B Reprolysin-like [PF13574.8, score=30.9]; Astacin (Peptidase family M12A) [PF01400.26, score=19.3]} {Human: ENSG00000140873, ADAMTS18, ADAM metallopeptidase with thrombospondin type 1 motif 18, [Score=90.9, Expect=1e-18]} {Mouse: ENSMUSG00000049538, Adamts16, a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 16, [Score=90.1, Expect=1e-18]; ENSMUSG00000053399, Adamts18, a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 18, [Score=89.7, Expect=2e-18]} {Dmel: FBgn0034903, sona, sol narae, [RH, Score=114, Expect=7e-27]} {Celegans: WBGene00003248, mig-17, ADAM family mig-17, [RH, Score=100, Expect=2e-22]} {RNA1509_42775} {RNA1310_19585.1, RNA1509_42775} {RNA1509_42775, RNA815_17997} |
| 52. | MligTC455_25073 | 1271 | 26.47 | Mlig455_015905 | Neo: - Age: logFC(26M/2M)=-0.947 Region-specific R2: 3.291 Region-enriched R2: 2.110/0.00052 |
PI16 | 2.752 | - | 0.846 | - | 0.953 | 0.953 | - | Mlig455_015905 {REF} {Length: 2189} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=71.8]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=111, Expect=1e-26]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [RH, Score=115, Expect=7e-28]} {Dmel: FBgn0038126, CG8483, [Score=95.1, Expect=2e-21]} {Celegans: WBGene00011462, vap-2, Venom-Allergen-like Protein, [RH, Score=85.5, Expect=3e-18]} {Smed: dd_Smed_v6_2512_0_1, dd_Smed_v6_2512_0_1, [Score=140, Expect=2e-39]} {RNA1509_36129, RNA1509_46021, RNA1509_5027} {RNA1310_1356.1, RNA1509_36129, RNA1509_46021} {RNA1509_36129, RNA1509_46021, RNA815_4508} |
| 53. | MligTC455_19410 | 194 | 4.04 | Mlig455_047838 | Neo: - Age: Down-Up-Up Region-specific R2: 5.170 Region-enriched R2: 5.689/0.00000 |
2.751 | - | - | 0.866 | 0.962 | 0.923 | - | Mlig455_047838 {REF} {Length: 724} {TRANSSPLICED} {RNA1509_54915} {RNA1310_53549} {RNA815_27051} | |
| 54. | MligTC455_27799 | 414 | 8.62 | Mlig455_004285, Mlig455_004370 | Neo: - Age: Down-Up-Down Region-specific R2: 3.850 Region-enriched R2: 5.047/0.00000 |
2.75 | - | 0.934 | - | 0.964 | 0.852 | - | Mlig455_004285 {REF} {Length: 650} {RNA1509_56105} {RNA1310_32410} {RNA815_17871.1} Mlig455_004370 {REF} {Length: 1653} {RNA1509_56105} {RNA1310_32410} {RNA815_17871.1} |
|
| 55. | MligTC455_44327 | 94 | 1.95 | Mlig455_026126 | Neo: - Age: Down-Down-Down Region-enriched R5: 3.905/0.02515 |
2.737 | - | 0.949 | 0.822 | 0.966 | - | - | Mlig455_026126 {REF} {Length: 572} {RNA1509_32102} {RNA1310_60068} {RNA815_37486} | |
| 56. | MligTC455_20350 | 434 | 9.05 | Mlig455_002780, Mlig455_066934 | Neo: - Age: - Region-enriched R2: 3.513/0.00619 |
SYT12 | 2.736 | - | 0.939 | - | 0.959 | 0.838 | - | Mlig455_002780 {REF} {Length: 2380} {Pfam: C2 domain [PF00168.32, score=69.7]} {Human: ENSG00000173227, SYT12, synaptotagmin 12, [Score=214, Expect=3e-64]} {Mouse: ENSMUSG00000049303, Syt12, synaptotagmin XII, [Score=207, Expect=1e-61]} {Dmel: FBgn0261085, Syt12, Synaptotagmin 12, [Score=182, Expect=3e-50]} {Celegans: WBGene00004921, snt-1, Synaptotagmin-1, [Score=142, Expect=2e-37]} {Smed: dd_Smed_v6_8032_0_1, dd_Smed_v6_8032_0_1, [Score=234, Expect=3e-72]} {RNA1310_10982.1} {RNA815_10652.1} Mlig455_066934 {REF} {Length: 2274} {Pfam: C2 domain [PF00168.32, score=69.7]} {Human: ENSG00000173227, SYT12, synaptotagmin 12, [Score=214, Expect=3e-64]} {Mouse: ENSMUSG00000049303, Syt12, synaptotagmin XII, [Score=206, Expect=1e-61]} {Dmel: FBgn0261085, Syt12, Synaptotagmin 12, [Score=182, Expect=3e-50]} {Celegans: WBGene00004921, snt-1, Synaptotagmin-1, [Score=142, Expect=2e-37]} {Smed: dd_Smed_v6_8032_0_1, dd_Smed_v6_8032_0_1, [Score=234, Expect=2e-72]} {RNA1310_10982.1} {RNA815_10652.1} |
| 57. | MligTC455_40779 | 191 | 3.98 | Mlig455_000277, Mlig455_035731, Mlig455_058356 | Neo: - Age: - Region-enriched R4: 3.665/0.04268 |
2.734 | - | 0.904 | 0.877 | 0.953 | - | - | Mlig455_000277 {REF} {Length: 1048} {RNA1509_16458} {RNA1310_43664.1} {RNA815_23166} Mlig455_035731 {REF} {Length: 1048} {RNA1509_16458} {RNA1310_43664.1} {RNA815_23166} Mlig455_058356 {REF} {Length: 1050} {RNA1509_16458} {RNA1310_43664.1} {RNA815_23166} |
|
| 58. | MligTC455_42484 | 246 | 5.12 | Mlig455_046416 | Neo: - Age: Down-Up-Down Region-specific R2: 4.313 Region-enriched R2: 2.983/0.00930 |
2.716 | - | 0.870 | - | 0.964 | 0.882 | - | Mlig455_046416 {REF} {Length: 1006} {RNA1310_40237.1} {RNA815_18246} | |
| 59. | MligTC455_34655 | 89 | 1.86 | Mlig455_058020, Mlig455_058176 | Neo: - Age: - Region-enriched R2: 5.798/0.00826 |
PPEF1 | 2.716 | - | 0.895 | 0.868 | 0.953 | - | - | Mlig455_058020 {REF} {Length: 3007} {Pfam: Calcineurin-like phosphoesterase [PF00149.30, score=84.9]; EF-hand domain pair [PF13499.8, score=77.8]; EF hand [PF00036.34, score=66.0]; EF-hand domain pair [PF13833.8, score=52.1]; EF-hand domain [PF13405.8, score=48.4]; EF hand [PF13202.8, score=38.2]; PPP5 TPR repeat region [PF08321.14, score=37.0]; EF-hand domain [PF14658.8, score=23.0]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=20.4]} {Human: ENSG00000086717, PPEF1, protein phosphatase with EF-hand domain 1, [Score=416, Expect=2e-138]} {Mouse: ENSMUSG00000062168, Ppef1, protein phosphatase with EF hand calcium-binding domain 1, [Score=413, Expect=9e-138]} {Dmel: FBgn0265959, rdgC, retinal degeneration C, [Score=404, Expect=3e-134]} {Celegans: WBGene00003969, pef-1, Serine/threonine-protein phosphatase with EF-hands pef-1, [Score=455, Expect=2e-155]} {Smed: dd_Smed_v6_11874_0_2, dd_Smed_v6_11874_0_2, [Score=516, Expect=2e-178]} {RNA1509_3508} {RNA1310_10928.2} {RNA815_11707} Mlig455_058176 {REF} {Length: 3371} {Pfam: Calcineurin-like phosphoesterase [PF00149.30, score=102.6]; EF-hand domain pair [PF13499.8, score=72.6]; EF hand [PF00036.34, score=64.2]; EF-hand domain pair [PF13833.8, score=51.3]; EF-hand domain [PF13405.8, score=46.1]; EF hand [PF13202.8, score=36.7]; PPP5 TPR repeat region [PF08321.14, score=36.6]; EF-hand domain [PF14658.8, score=26.5]; IQ calmodulin-binding motif [PF00612.29, score=21.3]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=19.8]} {Human: ENSG00000086717, PPEF1, protein phosphatase with EF-hand domain 1, [RH, Score=546, Expect=0.0]} {Mouse: ENSMUSG00000062168, Ppef1, protein phosphatase with EF hand calcium-binding domain 1, [Score=520, Expect=3e-177]} {Dmel: FBgn0265959, rdgC, retinal degeneration C, [Score=529, Expect=2e-180]} {Celegans: WBGene00003969, pef-1, Serine/threonine-protein phosphatase with EF-hands pef-1, [Score=598, Expect=0.0]} {Smed: dd_Smed_v6_11874_0_1, dd_Smed_v6_11874_0_1, [Score=671, Expect=0.0]} {RNA1509_3508} {RNA1310_10928.2} {RNA815_11707} |
| 60. | MligTC455_50806 | 257 | 5.36 | Mlig455_028471 | Neo: - Age: Up-Down-Up Region-specific R2: 3.748 Region-enriched R2: 3.524/0.00051 Regeneration-downregulated R2: -2.091 Regeneration-depleted R2: -2.091 |
2.704 | - | 0.926 | 0.825 | 0.953 | - | - | Mlig455_028471 {REF} {Length: 923} {Pfam: Pancreatic hormone peptide [PF00159.20, score=41.0]} {RNA1509_25155} {RNA1310_44043} {RNA815_21709} | |
| 61. | MligTC455_45021 | 381 | 7.95 | Mlig455_046686 | Neo: - Age: Down-Up-Up Region-enriched R2: 3.428/0.03156 |
AVP | 2.698 | - | 0.862 | - | 0.961 | 0.875 | - | Mlig455_046686 {REF} {Length: 1388} {Pfam: Neurohypophysial hormones, C-terminal Domain [PF00184.19, score=36.2]} {Human: ENSG00000101200, AVP, arginine vasopressin, [Score=54.3, Expect=2e-09]} {Mouse: ENSMUSG00000037727, Avp, arginine vasopressin, [Score=53.1, Expect=3e-09]} {RNA1509_50574} {RNA1310_38922} {RNA815_23813} |
| 62. | MligTC455_20013 | 777 | 16.18 | Mlig455_002334, Mlig455_002335, Mlig455_019758 | Neo: - Age: Down-Up-Up Region-enriched R2: 2.606/0.00058 |
STOM | 2.696 | - | 0.838 | - | 0.952 | 0.906 | - | Mlig455_002334 {REF} {Length: 2498} {Pfam: SPFH domain / Band 7 family [PF01145.27, score=113.3]} {Human: ENSG00000148175, STOM, stomatin, [Score=290, Expect=1e-95]; ENSG00000133115, STOML3, stomatin like 3, [Score=290, Expect=8e-96]} {Mouse: ENSMUSG00000027744, Stoml3, stomatin (Epb7.2)-like 3, [Score=288, Expect=6e-95]; ENSMUSG00000026880, Stom, stomatin, [Score=286, Expect=3e-94]} {Dmel: FBgn0260657, CG42540, [Score=301, Expect=9e-99]} {Celegans: WBGene00003166, mec-2, Mechanosensory protein 2, [Score=305, Expect=1e-100]} {Smed: dd_Smed_v6_16206_0_1, dd_Smed_v6_16206_0_1, [RH, Score=376, Expect=2e-129]} {RNA1509_30153, RNA1509_46680} {RNA1310_12353, RNA1509_30153, RNA1509_46680} {RNA1509_30153, RNA1509_46680, RNA815_4616.1} Mlig455_002335 {REF} {Length: 1313} {NoTransDecoderORF} {RNA1509_20999} {RNA1310_66086} {RNA815_7817} Mlig455_019758 {REF} {Length: 2302} {Pfam: SPFH domain / Band 7 family [PF01145.27, score=113.0]} {Human: ENSG00000148175, STOM, stomatin, [Score=290, Expect=9e-96]; ENSG00000133115, STOML3, stomatin like 3, [Score=290, Expect=8e-96]} {Mouse: ENSMUSG00000027744, Stoml3, stomatin (Epb7.2)-like 3, [Score=287, Expect=7e-95]; ENSMUSG00000026880, Stom, stomatin, [Score=286, Expect=3e-94]} {Dmel: FBgn0260657, CG42540, [Score=301, Expect=9e-99]} {Celegans: WBGene00003166, mec-2, Mechanosensory protein 2, [Score=305, Expect=1e-100]} {Smed: dd_Smed_v6_16206_0_1, dd_Smed_v6_16206_0_1, [RH, Score=377, Expect=5e-130]} {RNA1509_30153} {RNA1310_12353} {RNA815_4616.1} |
| 63. | MligTC455_52491 | 413 | 8.61 | Mlig455_041906 | Neo: - Age: logFC(26M/2M)=-0.855 Region-specific R2: 3.229 Region-enriched R2: 2.944/0.00036 |
2.688 | - | 0.822 | 0.892 | 0.974 | - | - | Mlig455_041906 {REF} {Length: 712} {RNA1509_31700} {RNA1310_225.1, RNA1509_31700} {RNA1509_31700, RNA815_107.1} | |
| 64. | MligTC455_33288 | 692 | 14.41 | Mlig455_061850 | Neo: - Age: Down-Up-Up Region-specific R2: 4.145 Region-enriched R2: 4.075/0.00000 |
2.687 | - | 0.943 | - | 0.983 | 0.761 | - | Mlig455_061850 {REF} {Length: 889} {RNA1509_48963} {RNA1310_87307} {RNA815_23468} | |
| 65. | MligTC455_44999 | 2214 | 46.12 | Mlig455_067394, Mlig455_069538 | Neo: - Age: Down-Up-Up Region-enriched R2: 2.840/0.00027 |
2.676 | - | 0.886 | - | 0.951 | 0.839 | - | Mlig455_067394 {REF} {Length: 401} {RNA1509_52966} {RNA1310_68651, RNA1509_52966} {RNA1509_52966, RNA815_33112.1} Mlig455_069538 {REF} {Length: 1759} {Celegans: WBGene00001446, flp-3, FMRFamide-like neuropeptides 3 SPLGTMRF-amide TPLGTMRF-amide SAEPFGTMRF-amide NPENDTPFGTMRF-amide ASEDALFGTMRF-amide EAEEPLGTMRF-amide SADDSAPFGTMRF-amide NPLGTMRF-amide, [Score=45.8, Expect=1e-06]} {RNA1509_13671} {RNA1310_56061} {RNA815_33112.1} |
|
| 66. | MligTC455_27678 | 355 | 7.4 | Mlig455_070610 | Neo: - Age: - Region-specific R2: 4.724 Region-enriched R2: 3.766/0.00062 |
2.674 | - | - | 0.867 | 0.955 | 0.852 | - | Mlig455_070610 {REF} {Length: 725} {RNA1509_17468, RNA1509_34237} {RNA1310_59474, RNA1509_17468, RNA1509_34237} {RNA1509_17468, RNA1509_34237, RNA815_28024} | |
| 67. | MligTC455_34524 | 155 | 3.22 | Mlig455_021291 | Neo: - Age: Down-Up-Down Region-specific R2: 4.905 Region-enriched R2: 4.200/0.01842 |
2.674 | - | 0.955 | 0.784 | 0.935 | - | - | Mlig455_021291 {REF} {Length: 1478} {NoTransDecoderORF} {RNA1509_56543} {RNA1310_26920, RNA1509_56543} {RNA1509_56543, RNA815_11718} | |
| 68. | MligTC455_48521 | 56 | 1.17 | Mlig455_004444 | Neo: - Age: - |
2.667 | - | 0.923 | 0.786 | 0.958 | - | - | Mlig455_004444 {REF} {Length: 3968} {Pfam: GDNF/GAS1 domain [PF02351.18, score=19.4]} {Smed: dd_Smed_v6_19517_0_1, dd_Smed_v6_19517_0_1, [RH, Score=111, Expect=3e-25]} {RNA1509_50708} {RNA1310_13399} {RNA815_27009} | |
| 69. | MligTC455_21719 | 441 | 9.18 | Mlig455_025497, Mlig455_025520, Mlig455_070509 | Neo: - Age: - |
SLC6A1 | 2.658 | - | 0.812 | - | 0.889 | 0.957 | - | Mlig455_025497 {REF} {Length: 3353} {Pfam: Sodium:neurotransmitter symporter family [PF00209.20, score=655.7]} {Human: ENSG00000157103, SLC6A1, solute carrier family 6 member 1, [RH, Score=592, Expect=0.0]} {Mouse: ENSMUSG00000030310, Slc6a1, solute carrier family 6 (neurotransmitter transporter, GABA), member 1, [RH, Score=592, Expect=0.0]} {Dmel: FBgn0039915, Gat, GABA transporter, [RH, Score=590, Expect=0.0]} {Celegans: WBGene00004910, snf-11, Transporter, [RH, Score=599, Expect=0.0]} {Smed: dd_Smed_v6_8169_0_1, dd_Smed_v6_8169_0_1, [RH, Score=652, Expect=0.0]} {RNA1509_27603} {RNA1310_5653.1} {RNA815_1806} Mlig455_025520 {REF} {Length: 3631} {Pfam: Sodium:neurotransmitter symporter family [PF00209.20, score=655.7]} {Human: ENSG00000157103, SLC6A1, solute carrier family 6 member 1, [RH, Score=592, Expect=0.0]} {Mouse: ENSMUSG00000030310, Slc6a1, solute carrier family 6 (neurotransmitter transporter, GABA), member 1, [RH, Score=592, Expect=0.0]} {Dmel: FBgn0039915, Gat, GABA transporter, [RH, Score=590, Expect=0.0]} {Celegans: WBGene00004910, snf-11, Transporter, [RH, Score=599, Expect=0.0]} {Smed: dd_Smed_v6_8169_0_1, dd_Smed_v6_8169_0_1, [RH, Score=652, Expect=0.0]} {RNA1509_27603} {RNA1310_5653.1, RNA1509_27603} {RNA1509_27603, RNA815_1806} Mlig455_070509 {REF} {Length: 3425} {Pfam: Sodium:neurotransmitter symporter family [PF00209.20, score=631.8]} {Human: ENSG00000157103, SLC6A1, solute carrier family 6 member 1, [RH, Score=576, Expect=0.0]} {Mouse: ENSMUSG00000030310, Slc6a1, solute carrier family 6 (neurotransmitter transporter, GABA), member 1, [RH, Score=577, Expect=0.0]} {Dmel: FBgn0039915, Gat, GABA transporter, [RH, Score=575, Expect=0.0]} {Celegans: WBGene00004910, snf-11, Transporter, [RH, Score=583, Expect=0.0]} {Smed: dd_Smed_v6_8169_0_1, dd_Smed_v6_8169_0_1, [RH, Score=636, Expect=0.0]} {RNA1509_27603} {RNA1310_5653.1} {RNA815_1806} |
| 70. | MligTC455_39064 | 110 | 2.28 | Mlig455_000222, Mlig455_058480 | Neo: Irradiation Age: - Region-enriched R2: 5.418/0.00017 |
OSBPL1A | 2.656 | - | 0.904 | - | 0.952 | 0.800 | - | Mlig455_000222 {REF} {Length: 2113} {Pfam: Oxysterol-binding protein [PF01237.20, score=414.5]} {Human: ENSG00000141447, OSBPL1A, oxysterol binding protein like 1A, [RH, Score=375, Expect=2e-116]; ENSG00000130703, OSBPL2, oxysterol binding protein like 2, [RH, Score=357, Expect=8e-115]} {Mouse: ENSMUSG00000044252, Osbpl1a, oxysterol binding protein-like 1A, [RH, Score=378, Expect=4e-122]; ENSMUSG00000039050, Osbpl2, oxysterol binding protein-like 2, [RH, Score=367, Expect=6e-119]} {Dmel: FBgn0034951, CG3860, [RH, Score=409, Expect=1e-135]} {Celegans: WBGene00008832, obr-2, Oxysterol Binding protein (OSBP) Related, [RH, Score=239, Expect=3e-71]} {Smed: dd_Smed_v6_3179_0_1, dd_Smed_v6_3179_0_1, [RH, Score=385, Expect=3e-126]} {RNA1509_29630} {RNA1310_38654} {RNA815_7740} Mlig455_058480 {REF} {Length: 2888} {TRANSSPLICED} {Pfam: Oxysterol-binding protein [PF01237.20, score=414.5]} {Human: ENSG00000141447, OSBPL1A, oxysterol binding protein like 1A, [RH, Score=375, Expect=2e-116]; ENSG00000130703, OSBPL2, oxysterol binding protein like 2, [RH, Score=357, Expect=8e-115]} {Mouse: ENSMUSG00000044252, Osbpl1a, oxysterol binding protein-like 1A, [RH, Score=378, Expect=4e-122]; ENSMUSG00000039050, Osbpl2, oxysterol binding protein-like 2, [RH, Score=367, Expect=6e-119]} {Dmel: FBgn0034951, CG3860, [RH, Score=409, Expect=1e-135]} {Celegans: WBGene00008832, obr-2, Oxysterol Binding protein (OSBP) Related, [RH, Score=239, Expect=3e-71]} {Smed: dd_Smed_v6_3179_0_1, dd_Smed_v6_3179_0_1, [RH, Score=385, Expect=3e-126]} {RNA1509_29630} {RNA1310_38654} {RNA815_26411} |
| 71. | MligTC455_17967 | 3579 | 74.57 | Mlig455_051723, Mlig455_051747 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.373 Region-enriched R2: 2.354/0.00024 |
2.655 | 0.811 | - | - | 0.892 | 0.952 | - | Mlig455_051723 {REF} {Length: 1123} {Pfam: YqbF, hypothetical protein domain [PF14553.8, score=33.4]; Zinc-finger of nitric oxide synthase-interacting protein [PF15906.7, score=21.7]; Protein of unknown function (DUF559) [PF04480.14, score=20.6]} {RNA1509_16925} {RNA1310_34603.1} {RNA815_20381} Mlig455_051747 {REF} {Length: 1166} {Pfam: YqbF, hypothetical protein domain [PF14553.8, score=36.0]; Zinc-finger of nitric oxide synthase-interacting protein [PF15906.7, score=25.9]; Protein of unknown function (DUF559) [PF04480.14, score=22.5]; REase_MTES_1575 [PF18741.3, score=20.8]; CW_7 repeat [PF08230.13, score=19.3]} {RNA1509_16925} {RNA1310_34603.1} {RNA815_20381} |
|
| 72. | MligTC455_11473 | 248 | 5.17 | Mlig455_009711, Mlig455_071036 | Neo: - Age: Down-Up-Down |
CHRNA3 | 2.651 | - | 0.955 | 0.807 | - | 0.889 | - | Mlig455_009711 {REF} {Length: 2402} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=241.4]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=222.9]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=391, Expect=2e-130]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=379, Expect=6e-126]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=375, Expect=2e-124]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=390, Expect=2e-130]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=375, Expect=2e-124]} {Dmel: FBgn0000038, nAChRbeta1, nicotinic Acetylcholine Receptor beta1, [RH, Score=499, Expect=9e-173]} {Celegans: WBGene00000043, acr-3, Acetylcholine receptor subunit beta-type acr-3, [RH, Score=426, Expect=6e-145]} {Smed: dd_Smed_v6_12146_0_1, dd_Smed_v6_12146_0_1, [Score=510, Expect=1e-176]} {RNA1509_48201} {RNA1310_10118} {RNA815_29940} Mlig455_071036 {REF} {Length: 746} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=28.1]} {Dmel: FBgn0000038, nAChRbeta1, nicotinic Acetylcholine Receptor beta1, [Score=63.5, Expect=2e-13]} {Celegans: WBGene00000042, acr-2, Acetylcholine receptor subunit beta-type acr-2, [Score=63.9, Expect=9e-14]} {Smed: dd_Smed_v6_12535_0_1, dd_Smed_v6_12535_0_1, [Score=64.3, Expect=6e-14]} {RNA1310_21182} {RNA815_29940} |
| 73. | MligTC455_42485 | 159 | 3.31 | Mlig455_046457 | Neo: - Age: - |
2.645 | - | 0.887 | - | 0.960 | 0.798 | - | Mlig455_046457 {REF} {Length: 846} {RNA1310_40237.1} {RNA815_18246} | |
| 74. | MligTC455_19279 | 4576 | 95.33 | Mlig455_057411 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=-0.654 Region-specific R2: 5.173 Region-enriched R2: 4.585/0.00000 |
CHRNA10 | 2.638 | 0.816 | 0.954 | 0.868 | - | - | - | Mlig455_057411 {REF} {Length: 1075} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=85.3]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=91.3, Expect=1e-20]} {Mouse: ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=92.0, Expect=7e-21]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=88.2, Expect=1e-19]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=110, Expect=2e-27]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=120, Expect=4e-31]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=96.3, Expect=8e-23]} {RNA1509_1306} {RNA1310_34970} {RNA815_15305.1} |
| 75. | MligTC455_16781 | 32 | 0.67 | Mlig455_003020, Mlig455_003313 | Neo: - Age: - |
2.637 | - | 0.873 | 0.807 | 0.957 | - | - | Mlig455_003020 {REF} {Length: 518} {Pfam: Immunoreceptor tyrosine-based activation motif [PF02189.17, score=26.8]} {RNA1310_57787} {RNA815_49158} Mlig455_003313 {REF} {Length: 905} {Pfam: Immunoreceptor tyrosine-based activation motif [PF02189.17, score=74.4]} {RNA1310_57787} {RNA815_49158} |
|
| 76. | MligTC455_48063 | 63 | 1.31 | Mlig455_046268 | Neo: - Age: - Region-enriched R2: 5.256/0.00170 |
2.637 | - | 0.845 | - | 0.952 | 0.840 | - | Mlig455_046268 {REF} {Length: 749} {RNA1310_88363} {RNA815_47885} | |
| 77. | MligTC455_02855 | 144 | 3 | Mlig455_000237 | Neo: - Age: - |
B3GALT2 | 2.634 | - | 0.877 | - | 0.950 | 0.807 | - | Mlig455_000237 {REF} {Length: 757} {Pfam: Galactosyltransferase [PF01762.23, score=48.0]} {Human: ENSG00000162630, B3GALT2, beta-1,3-galactosyltransferase 2, [Score=48.5, Expect=8e-07]} {Mouse: ENSMUSG00000033849, B3galt2, UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2, [Score=48.5, Expect=6e-07]} {Dmel: FBgn0035558, CG11357, [Score=61.6, Expect=1e-11]} {Smed: dd_Smed_v6_4748_0_1, dd_Smed_v6_4748_0_1, [Score=88.2, Expect=2e-21]} {RNA1509_17403} {RNA1310_48383} {RNA815_28728} |
| 78. | MligTC455_25313 | 529 | 11.03 | Mlig455_047806, Mlig455_047883 | Neo: - Age: Up-Down-Down |
PCLO | 2.621 | - | 0.931 | 0.734 | 0.956 | - | - | Mlig455_047806 {REF} {Length: 4640} {Pfam: C2 domain [PF00168.32, score=102.8]; PDZ domain [PF17820.3, score=23.7]} {Human: ENSG00000186472, PCLO, piccolo presynaptic cytomatrix protein, [Score=115, Expect=2e-25]} {Mouse: ENSMUSG00000061601, Pclo, piccolo (presynaptic cytomatrix protein), [RH, Score=117, Expect=4e-26]} {Dmel: FBgn0003091, Pkc53E, Protein C kinase 53E, [Score=83.2, Expect=4e-16]} {Celegans: WBGene00004033, pkc-2, Protein kinase C-like 2, [Score=79.0, Expect=7e-15]} {Smed: dd_Smed_v6_9615_0_2, dd_Smed_v6_9615_0_2, [RH, Score=198, Expect=2e-52]} {RNA1509_12877} {RNA1310_21392} {RNA815_8186} Mlig455_047883 {REF} {Length: 3110} {Smed: dd_Smed_v6_9615_0_2, dd_Smed_v6_9615_0_2, [RH, Score=192, Expect=2e-55]} {RNA1509_12877} {RNA1310_21392} {RNA815_8186} |
| 79. | MligTC455_33280 | 127 | 2.64 | Mlig455_010523 | Neo: - Age: Down-Up-Up |
2.619 | - | 0.835 | 0.823 | 0.961 | - | - | Mlig455_010523 {REF} {Length: 587} {RNA1509_48963} {RNA1310_65789} {RNA815_23468} | |
| 80. | MligTC455_25703 | 225 | 4.7 | Mlig455_017402, Mlig455_030916 | Neo: - Age: - |
2.614 | - | - | 0.957 | 0.910 | 0.747 | - | Mlig455_017402 {REF} {Length: 899} {RNA1310_52753} {RNA815_26527} Mlig455_030916 {REF} {Length: 700} {RNA1310_52753} {RNA815_26527} |
|
| 81. | MligTC455_43236 | 107 | 2.24 | Mlig455_039667 | Neo: - Age: Down-Down-Up |
CAMKK2 | 2.607 | - | - | 0.785 | 0.953 | 0.869 | - | Mlig455_039667 {REF} {Length: 2203} {Pfam: Protein kinase domain [PF00069.27, score=200.7]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=113.0]; Kinase-like [PF14531.8, score=26.6]} {Human: ENSG00000110931, CAMKK2, calcium/calmodulin dependent protein kinase kinase 2, [Score=381, Expect=9e-125]; ENSG00000004660, CAMKK1, calcium/calmodulin dependent protein kinase kinase 1, [Score=364, Expect=2e-118]} {Mouse: ENSMUSG00000029471, Camkk2, calcium/calmodulin-dependent protein kinase kinase 2, beta, [Score=374, Expect=5e-122]; ENSMUSG00000020785, Camkk1, calcium/calmodulin-dependent protein kinase kinase 1, alpha, [Score=359, Expect=1e-116]} {Dmel: FBgn0040056, CG17698, [Score=358, Expect=2e-114]} {Celegans: WBGene00000518, ckk-1, Calcium/calmodulin-dependent protein kinase kinase, [Score=363, Expect=1e-119]} {Smed: dd_Smed_v6_18437_0_1, dd_Smed_v6_18437_0_1, [Score=338, Expect=9e-108]} {RNA1310_35311.1} {RNA815_49857} |
| 82. | MligTC455_09874 | 31 | 0.65 | Mlig455_045071 | Neo: - Age: - |
DOC2A | 2.601 | - | - | 0.760 | 0.960 | 0.881 | - | Mlig455_045071 {REF} {Length: 1760} {Pfam: C2 domain [PF00168.32, score=55.9]} {Human: ENSG00000149927, DOC2A, double C2 domain alpha, [Score=55.8, Expect=7e-08]} {Mouse: ENSMUSG00000052301, Doc2a, double C2, alpha, [Score=55.5, Expect=7e-08]} {Celegans: WBGene00004923, snt-3, SyNapTotagmin, [Score=70.5, Expect=2e-13]} {Smed: dd_Smed_v6_16731_0_1, dd_Smed_v6_16731_0_1, [Score=112, Expect=7e-27]} {RNA1310_36283} {RNA815_40844} |
| 83. | MligTC455_25135 | 288 | 6 | Mlig455_001749, Mlig455_001771 | Neo: - Age: - Region-enriched R2: 2.329/0.04280 |
P2RX4 | 2.599 | - | 0.764 | - | 0.884 | 0.951 | - | Mlig455_001749 {REF} {Length: 2951} {Pfam: ATP P2X receptor [PF00864.21, score=341.3]} {Human: ENSG00000135124, P2RX4, purinergic receptor P2X 4, [Score=247, Expect=3e-75]; ENSG00000187848, P2RX2, purinergic receptor P2X 2, [Score=235, Expect=5e-70]} {Mouse: ENSMUSG00000029470, P2rx4, purinergic receptor P2X, ligand-gated ion channel 4, [Score=248, Expect=1e-75]; ENSMUSG00000029503, P2rx2, purinergic receptor P2X, ligand-gated ion channel, 2, [Score=236, Expect=3e-70]} {Smed: dd_Smed_v6_10968_0_1, dd_Smed_v6_10968_0_1, [Score=316, Expect=7e-101]} {RNA1509_56054} {RNA1310_19416, RNA1509_56054} {RNA1509_56054, RNA815_42167} Mlig455_001771 {REF} {Length: 2484} {Pfam: ATP P2X receptor [PF00864.21, score=341.3]} {Human: ENSG00000135124, P2RX4, purinergic receptor P2X 4, [Score=247, Expect=3e-75]; ENSG00000187848, P2RX2, purinergic receptor P2X 2, [Score=235, Expect=5e-70]} {Mouse: ENSMUSG00000029470, P2rx4, purinergic receptor P2X, ligand-gated ion channel 4, [Score=248, Expect=1e-75]; ENSMUSG00000029503, P2rx2, purinergic receptor P2X, ligand-gated ion channel, 2, [Score=236, Expect=3e-70]} {Smed: dd_Smed_v6_10968_0_1, dd_Smed_v6_10968_0_1, [Score=316, Expect=7e-101]} {RNA1509_56054} {RNA1310_19416} {RNA815_42167} |
| 84. | MligTC455_25921 | 329 | 6.86 | Mlig455_006703 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-2.996 Region-enriched R2: 6.614/0.00492 |
2.597 | - | 0.742 | - | 0.903 | 0.952 | - | Mlig455_006703 {REF} {Length: 664} {RNA1509_22927} {RNA1310_80445} {RNA815_41771.1} | |
| 85. | MligTC455_24272 | 197 | 4.1 | Mlig455_005121, Mlig455_005189 | Neo: - Age: Down-Up-Down |
CHRNA7 | 2.596 | - | 0.789 | - | 0.964 | 0.843 | - | Mlig455_005121 {REF} {Length: 1737} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=104.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=68.3]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=135, Expect=4e-34]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=134, Expect=3e-34]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=134, Expect=3e-34]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=131, Expect=3e-33]; ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=127, Expect=5e-32]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=119, Expect=6e-29]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=129, Expect=1e-32]} {Smed: dd_Smed_v6_12182_0_1, dd_Smed_v6_12182_0_1, [Score=120, Expect=2e-29]} {RNA1509_43533} {RNA1310_19997.1, RNA1509_43533} {RNA1509_43533, RNA815_7971} Mlig455_005189 {REF} {Length: 1477} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=101.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=68.4]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=136, Expect=2e-34]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=136, Expect=1e-34]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=136, Expect=2e-34]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=133, Expect=8e-34]; ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=128, Expect=4e-32]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=117, Expect=4e-28]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=130, Expect=1e-32]} {Smed: dd_Smed_v6_12182_0_1, dd_Smed_v6_12182_0_1, [Score=117, Expect=3e-28]} {RNA1509_43533} {RNA1310_19997.1} {RNA815_7971} |
| 86. | MligTC455_33511 | 496 | 10.33 | Mlig455_019112 | Neo: - Age: - Region-enriched R2: 2.637/0.00674 |
INPP1 | 2.588 | - | - | 0.719 | 0.904 | 0.965 | - | Mlig455_019112 {REF} {Length: 2860} {Pfam: Inositol monophosphatase family [PF00459.27, score=118.2]} {Human: ENSG00000151689, INPP1, inositol polyphosphate-1-phosphatase, [RH, Score=262, Expect=4e-83]} {Mouse: ENSMUSG00000026102, Inpp1, inositol polyphosphate-1-phosphatase, [RH, Score=297, Expect=7e-97]} {Dmel: FBgn0016672, Ipp, Inositol polyphosphate 1-phosphatase, [RH, Score=252, Expect=6e-80]} {Celegans: WBGene00044063, bpnt-1, 3'(2'), 5'-BisPhosphate NucleoTidase 1 homolog, [Score=74.7, Expect=1e-14]} {Smed: dd_Smed_v6_9612_0_1, dd_Smed_v6_9612_0_1, [RH, Score=197, Expect=6e-59]} {RNA1509_8591} {RNA1310_6898.1} {RNA815_7520} |
| 87. | MligTC455_29725 | 72 | 1.49 | Mlig455_014390 | Neo: - Age: - Region-enriched R2: 7.905/0.00012 |
OTOP2 | 2.582 | - | - | 0.778 | 0.953 | 0.851 | - | Mlig455_014390 {REF} {Length: 2547} {Pfam: Otopetrin [PF03189.15, score=220.6]} {Human: ENSG00000183034, OTOP2, otopetrin 2, [Score=52.0, Expect=3e-06]; ENSG00000163982, OTOP1, otopetrin 1, [Score=49.7, Expect=1e-05]} {Mouse: ENSMUSG00000051596, Otop1, otopetrin 1, [Score=53.5, Expect=7e-07]; ENSMUSG00000050201, Otop2, otopetrin 2, [Score=51.6, Expect=3e-06]} {Dmel: FBgn0259150, CG42265, [Score=177, Expect=3e-46]} {Celegans: WBGene00017034, otpl-2, OToPetrin-Like, [Score=101, Expect=2e-22]} {Smed: dd_Smed_v6_13612_0_3, dd_Smed_v6_13612_0_3, [Score=276, Expect=7e-84]} {RNA1310_55206} {RNA815_48323} |
| 88. | MligTC455_33707 | 211 | 4.4 | Mlig455_018361 | Neo: - Age: - |
XRRA1 | 2.566 | - | 0.803 | - | 0.799 | 0.964 | - | Mlig455_018361 {REF} {Length: 3845} {Pfam: Leucine Rich repeats (2 copies) [PF12799.9, score=41.5]; Leucine rich repeat [PF13855.8, score=28.9]} {Human: ENSG00000166435, XRRA1, X-ray radiation resistance associated 1, [RH, Score=167, Expect=1e-45]} {Mouse: ENSMUSG00000035211, Xrra1, X-ray radiation resistance associated 1, [RH, Score=171, Expect=1e-43]} {Celegans: WBGene00006820, unc-89, Muscle M-line assembly protein unc-89, [Score=63.9, Expect=7e-10]} {Smed: dd_Smed_v6_13519_0_1, dd_Smed_v6_13519_0_1, [RH, Score=154, Expect=3e-38]} {RNA1509_45583} {RNA1310_16743.1} {RNA815_17679} |
| 89. | MligTC455_51806 | 83 | 1.73 | Mlig455_037702, Mlig455_046362 | Neo: - Age: - |
GPSM2 | 2.566 | - | - | 0.772 | 0.958 | 0.836 | - | Mlig455_037702 {REF} {Length: 3216} {Pfam: Tetratricopeptide repeat [PF13424.8, score=100.7]; Tetratricopeptide repeat [PF13176.8, score=98.7]; Tetratricopeptide repeat [PF00515.30, score=93.3]; GoLoco motif [PF02188.19, score=66.5]; Tetratricopeptide repeat [PF07719.19, score=54.7]; Tetratricopeptide repeat [PF13181.8, score=43.2]; Tetratricopeptide repeat [PF13374.8, score=34.5]; Rapsyn N-terminal myristoylation and linker region [PF10579.11, score=20.8]} {Human: ENSG00000121957, GPSM2, G protein signaling modulator 2, [RH, Score=521, Expect=3e-176]} {Mouse: ENSMUSG00000026930, Gpsm1, G-protein signalling modulator 1 (AGS3-like, C. elegans), [RH, Score=494, Expect=2e-166]} {Dmel: FBgn0040080, pins, partner of inscuteable, [RH, Score=534, Expect=0.0]} {Celegans: WBGene00000092, ags-3, Activator of G protein Signalling, [Score=256, Expect=4e-76]} {Smed: dd_Smed_v6_6548_1_1, dd_Smed_v6_6548_1_1, [RH, Score=462, Expect=3e-154]} {RNA1310_18538} {RNA815_41322} Mlig455_046362 {REF} {Length: 3324} {Pfam: Tetratricopeptide repeat [PF13424.8, score=119.4]; Tetratricopeptide repeat [PF13176.8, score=96.3]; Tetratricopeptide repeat [PF00515.30, score=93.0]; GoLoco motif [PF02188.19, score=85.6]; Tetratricopeptide repeat [PF07719.19, score=54.4]; Tetratricopeptide repeat [PF13181.8, score=42.7]; Tetratricopeptide repeat [PF13374.8, score=34.2]; Rapsyn N-terminal myristoylation and linker region [PF10579.11, score=21.7]} {Human: ENSG00000121957, GPSM2, G protein signaling modulator 2, [Score=545, Expect=0.0]} {Mouse: ENSMUSG00000027883, Gpsm2, G-protein signalling modulator 2 (AGS3-like, C. elegans), [RH, Score=535, Expect=0.0]} {Dmel: FBgn0040080, pins, partner of inscuteable, [RH, Score=531, Expect=1e-180]} {Celegans: WBGene00000092, ags-3, Activator of G protein Signalling, [RH, Score=266, Expect=1e-79]} {Smed: dd_Smed_v6_6548_1_1, dd_Smed_v6_6548_1_1, [RH, Score=474, Expect=1e-158]} {RNA1310_18538} {RNA815_41322} |
| 90. | MligTC455_19280 | 21417 | 446.19 | Mlig455_057387, Mlig455_059547 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.621 Region-enriched R2: 3.570/0.00141 |
CHRNA10 | 2.562 | 0.887 | 0.951 | - | - | - | 0.724 | Mlig455_057387 {REF} {Length: 1088} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=87.8]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=95.5, Expect=6e-22]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=95.5, Expect=4e-22]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=94.7, Expect=1e-21]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=94.0, Expect=2e-21]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=109, Expect=6e-27]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=120, Expect=8e-31]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=97.4, Expect=5e-23]} {RNA1509_1306, RNA1509_1333, RNA1509_15501} {RNA1310_34970, RNA1509_1333, RNA1509_15501} {RNA1509_1333, RNA1509_15501, RNA815_15305.1} Mlig455_059547 {REF} {Length: 1084} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=85.3]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=91.3, Expect=1e-20]} {Mouse: ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=92.0, Expect=7e-21]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=88.2, Expect=1e-19]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=110, Expect=2e-27]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=120, Expect=4e-31]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=96.3, Expect=8e-23]} {RNA1509_1306} {RNA1310_34970} {RNA815_15305.1} |
| 91. | MligTC455_50171 | 151 | 3.14 | Mlig455_065462 | Neo: - Age: logFC(26M/2M)=0.548 Region-specific R2: 5.212 Region-enriched R2: 5.063/0.00089 Regeneration-downregulated R2: -2.783 Regeneration-depleted R2: -2.783 |
SCNN1A | 2.562 | - | 0.744 | 0.854 | 0.964 | - | - | Mlig455_065462 {REF} {Length: 3905} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=185.3]} {Human: ENSG00000111319, SCNN1A, sodium channel epithelial 1 alpha subunit, [Score=60.1, Expect=9e-09]} {Mouse: ENSMUSG00000030340, Scnn1a, sodium channel, nonvoltage-gated 1 alpha, [Score=67.0, Expect=5e-11]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=92.8, Expect=1e-19]} {Smed: dd_Smed_v6_16959_0_1, dd_Smed_v6_16959_0_1, [Score=275, Expect=3e-83]} {RNA1509_60030} {RNA1310_56761} {RNA815_31877.1} |
| 92. | MligTC455_44050 | 2086 | 43.46 | Mlig455_028045, Mlig455_028051 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.242 Region-specific R2: 6.161 Region-enriched R2: 7.072/0.00000 |
2.556 | - | 0.957 | 0.807 | - | 0.792 | - | Mlig455_028045 {REF} {Length: 1156} {RNA1509_31459, RNA1509_3903} {RNA1310_2730.2, RNA1509_31459, RNA1509_3903} {RNA1509_31459, RNA1509_3903, RNA815_7682} Mlig455_028051 {REF} {Length: 871} {NoTransDecoderORF} {RNA1509_3903} {RNA1310_15260} {RNA815_7682} |
|
| 93. | MligTC455_25766 | 42 | 0.88 | Mlig455_008785, Mlig455_008821, Mlig455_008919 | Neo: - Age: - Region-enriched R2: 5.588/0.00166 |
2.553 | - | 0.723 | 0.870 | 0.960 | - | - | Mlig455_008785 {REF} {Length: 1744} {RNA1310_20437} {RNA815_15201} Mlig455_008821 {REF} {Length: 2074} {RNA1310_20437} {RNA815_15201} Mlig455_008919 {REF} {Length: 2074} {RNA1310_20437} {RNA815_15201} |
|
| 94. | MligTC455_48523 | 615 | 12.81 | Mlig455_027573 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.661 Region-enriched R2: 5.785/0.00008 |
2.548 | - | - | 0.823 | 0.951 | 0.774 | - | Mlig455_027573 {REF} {Length: 1106} {TRANSSPLICED} {Pfam: N-formylglutamate amidohydrolase [PF05013.14, score=30.2]} {RNA1509_25119, RNA1509_35691, RNA1509_59740} {RNA1310_12591, RNA1509_25119, RNA1509_35691, RNA1509_59740} {RNA1509_25119, RNA1509_35691, RNA1509_59740, RNA815_14574} | |
| 95. | MligTC455_15329 | 22 | 0.47 | Mlig455_060498 | Neo: - Age: - |
2.546 | - | 0.701 | - | 0.950 | 0.895 | - | Mlig455_060498 {REF} {Length: 1186} {Pfam: PAN domain [PF00024.28, score=18.9]} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [Score=63.9, Expect=4e-12]} {RNA1310_37660} {RNA815_17816.1} | |
| 96. | MligTC455_15182 | 24 | 0.49 | Mlig455_008075 | Neo: - Age: - |
2.542 | - | 0.705 | - | 0.951 | 0.886 | - | Mlig455_008075 {REF} {Length: 1623} {RNA1310_145272} | |
| 97. | MligTC455_50348 | 34 | 0.7 | Mlig455_012803 | Neo: - Age: - |
2.539 | - | 0.828 | 0.759 | 0.952 | - | - | Mlig455_012803 {REF} {Length: 488} {RNA1509_48155} {RNA1310_70969.2} {RNA815_39712} | |
| 98. | MligTC455_47197 | 155 | 3.24 | Mlig455_049096, Mlig455_049118 | Neo: - Age: - |
2.535 | - | - | 0.750 | 0.812 | 0.973 | - | Mlig455_049096 {REF} {Length: 3209} {Smed: dd_Smed_v6_14861_0_1, dd_Smed_v6_14861_0_1, [Score=151, Expect=1e-37]} {RNA1509_52343} {RNA1310_44918.1} {RNA815_41725} Mlig455_049118 {REF} {Length: 3116} {Smed: dd_Smed_v6_14861_0_1, dd_Smed_v6_14861_0_1, [Score=160, Expect=1e-40]} {RNA1509_52343} {RNA1310_44918.1} {RNA815_41725} |
|
| 99. | MligTC455_26678 | 44 | 0.92 | Mlig455_004705 | Neo: - Age: - |
2.514 | - | 0.834 | 0.728 | 0.952 | - | - | Mlig455_004705 {REF} {Length: 311} {NoTransDecoderORF} {RNA1310_55436} {RNA815_42049.1} | |
| 100. | MligTC455_50669 | 1941 | 40.44 | Mlig455_004231, Mlig455_031063 | Neo: - Age: logFC(26M/2M)=-0.342 |
VWA3A | 2.491 | - | 0.726 | - | - | 0.951 | 0.814 | Mlig455_004231 {REF} {Length: 4288} {Pfam: von Willebrand factor type A domain [PF13768.8, score=204.1]; von Willebrand factor type A domain [PF00092.30, score=57.9]; von Willebrand factor type A domain [PF13519.8, score=50.5]; VWA domain containing CoxE-like protein [PF05762.16, score=24.5]} {Human: ENSG00000283835, VWA3A, von Willebrand factor A domain containing 3A, [RH, Score=889, Expect=0.0]; ENSG00000175267, VWA3A, von Willebrand factor A domain containing 3A, [RH, Score=887, Expect=0.0]} {Mouse: ENSMUSG00000030889, Vwa3a, von Willebrand factor A domain containing 3A, [RH, Score=840, Expect=0.0]} {Smed: dd_Smed_v6_10972_0_2, dd_Smed_v6_10972_0_2, [RH, Score=1105, Expect=0.0]} {RNA1509_3167} {RNA1310_447.1} {RNA815_579} Mlig455_031063 {REF} {Length: 4311} {Pfam: von Willebrand factor type A domain [PF13768.8, score=203.9]; von Willebrand factor type A domain [PF00092.30, score=57.7]; von Willebrand factor type A domain [PF13519.8, score=50.3]; VWA domain containing CoxE-like protein [PF05762.16, score=24.4]} {Human: ENSG00000283835, VWA3A, von Willebrand factor A domain containing 3A, [RH, Score=890, Expect=0.0]; ENSG00000175267, VWA3A, von Willebrand factor A domain containing 3A, [RH, Score=888, Expect=0.0]} {Mouse: ENSMUSG00000030889, Vwa3a, von Willebrand factor A domain containing 3A, [RH, Score=840, Expect=0.0]} {Smed: dd_Smed_v6_10972_0_2, dd_Smed_v6_10972_0_2, [RH, Score=1104, Expect=0.0]} {RNA1509_3167} {RNA1310_447.1, RNA1509_3167} {RNA1509_3167, RNA815_579} |
There are 77 more genes with r >= 0.95